140 related articles for article (PubMed ID: 37327924)
1. Study of folate-based carbon nanotube drug delivery systems targeted to folate receptor α by molecular dynamic simulations.
Jiang Y; Wang C; Zhang M; Liu L; Gao X; Zhang S; Ye D
Int J Biol Macromol; 2023 Jul; 244():125386. PubMed ID: 37327924
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics insight of interaction between the functionalized-carbon nanotube and cancerous cell membrane in doxorubicin delivery.
Kordzadeh A; Zarif M; Amjad-Iranagh S
Comput Methods Programs Biomed; 2023 Mar; 230():107332. PubMed ID: 36603233
[TBL] [Abstract][Full Text] [Related]
3. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
[TBL] [Abstract][Full Text] [Related]
4. Intermediate states in the binding process of folic acid to folate receptor α: insights by molecular dynamics and metadynamics.
Della-Longa S; Arcovito A
J Comput Aided Mol Des; 2015 Jan; 29(1):23-35. PubMed ID: 25323390
[TBL] [Abstract][Full Text] [Related]
5. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
Mizusako H; Tagami T; Hattori K; Ozeki T
J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976
[TBL] [Abstract][Full Text] [Related]
7. Preparation and properties of carbon nanotube (Fe)/hydroxyapatite composite as magnetic targeted drug delivery carrier.
Li H; Sun X; Li Y; Li B; Liang C; Wang H
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():222-229. PubMed ID: 30678906
[TBL] [Abstract][Full Text] [Related]
8. Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study.
Al-Thiabat MG; Gazzali AM; Mohtar N; Murugaiyah V; Kamarulzaman EE; Yap BK; Rahman NA; Othman R; Wahab HA
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500740
[TBL] [Abstract][Full Text] [Related]
9. Understanding the co-loading and releasing of doxorubicin and paclitaxel using chitosan functionalized single-walled carbon nanotubes by molecular dynamics simulations.
Karnati KR; Wang Y
Phys Chem Chem Phys; 2018 Apr; 20(14):9389-9400. PubMed ID: 29565091
[TBL] [Abstract][Full Text] [Related]
10. Carbon Nanotubes Having Haeckelite Defects as Potential Drug Carriers. Molecular Dynamics Simulation.
Torres C; Villarroel I; Rozas R; Contreras L
Molecules; 2019 Nov; 24(23):. PubMed ID: 31771295
[TBL] [Abstract][Full Text] [Related]
11. Adsorption and encapsulation of the drug doxorubicin on covalent functionalized carbon nanotubes: A scrutinized study by using molecular dynamics simulation and quantum mechanics calculation.
Kordzadeh A; Amjad-Iranagh S; Zarif M; Modarress H
J Mol Graph Model; 2019 May; 88():11-22. PubMed ID: 30616088
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin Encapsulation in Carbon Nanotubes Having Haeckelite or Stone-Wales Defects as Drug Carriers: A Molecular Dynamics Approach.
Contreras L; Villarroel I; Torres C; Rozas R
Molecules; 2021 Mar; 26(6):. PubMed ID: 33805628
[TBL] [Abstract][Full Text] [Related]
13. Heterocyclic Substitutions Greatly Improve Affinity and Stability of Folic Acid towards FRα. an In Silico Insight.
Al-Thiabat MG; Saqallah FG; Gazzali AM; Mohtar N; Yap BK; Choong YS; Wahab HA
Molecules; 2021 Feb; 26(4):. PubMed ID: 33670773
[TBL] [Abstract][Full Text] [Related]
14. An MD-based systematic study on the mechanical characteristics of a novel hybrid CNT/graphene drug carrier.
Mohebali M; Rezapour N; Shadmani P; Montazeri A
J Mol Model; 2020 Aug; 26(9):241. PubMed ID: 32814981
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor-targeted hybrid lipid-core nanocapsules for sequential delivery of doxorubicin and tanespimycin.
Gupta B; Pathak S; Poudel BK; Regmi S; Ruttala HB; Gautam M; Lee JS; Jeong JH; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2017 Jul; 155():83-92. PubMed ID: 28410515
[TBL] [Abstract][Full Text] [Related]
16. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
[TBL] [Abstract][Full Text] [Related]
17. TRPV1 channel as a target for cancer therapy using CNT-based drug delivery systems.
Ortega-Guerrero A; Espinosa-Duran JM; Velasco-Medina J
Eur Biophys J; 2016 Jul; 45(5):423-33. PubMed ID: 26872481
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate.
Mohammed AFA; Higashi T; Motoyama K; Ohyama A; Onodera R; Khaled KA; Sarhan HA; Hussein AK; Arima H
AAPS J; 2019 Apr; 21(4):54. PubMed ID: 30993472
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulation study of doxorubicin adsorption on functionalized carbon nanotubes with folic acid and tryptophan.
Arabian T; Amjad-Iranagh S; Halladj R
Sci Rep; 2021 Dec; 11(1):24210. PubMed ID: 34930942
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulation of doxorubicin adsorption on a bundle of functionalized CNT.
Izadyar A; Farhadian N; Chenarani N
J Biomol Struct Dyn; 2016 Aug; 34(8):1797-805. PubMed ID: 26375507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
